CHECK CAP LTD (CHEK)
IL0011336851 - Common Stock
Taking everything into account, CHEK scores 2 out of 10 in our fundamental rating. CHEK was compared to 187 industry peers in the Health Care Equipment & Supplies industry. CHEK has a great financial health rating, but its profitability evaluates not so good. CHEK does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year CHEK has reported negative net income.
CHEK had a negative operating cash flow in the past year.
CHEK had negative earnings in each of the past 5 years.
CHEK had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -70.22%, CHEK is doing worse than 75.94% of the companies in the same industry.
CHEK has a worse Return On Equity (-74.17%) than 60.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -70.22% | ||
| ROE | -74.17% | ||
| ROIC | N/A |
ROA(3y)-47.73%
ROA(5y)-72.09%
ROE(3y)-51.45%
ROE(5y)-92.21%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
CHEK does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
The number of shares outstanding for CHEK remains at a similar level compared to 1 year ago.
The number of shares outstanding for CHEK has been increased compared to 5 years ago.
CHEK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
CHEK has an Altman-Z score of -5.24. This is a bad value and indicates that CHEK is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CHEK (-5.24) is worse than 71.12% of its industry peers.
CHEK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -5.24 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
CHEK has a Current Ratio of 18.69. This indicates that CHEK is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 18.69, CHEK belongs to the top of the industry, outperforming 98.93% of the companies in the same industry.
CHEK has a Quick Ratio of 18.69. This indicates that CHEK is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of CHEK (18.69) is better than 98.93% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 18.69 | ||
| Quick Ratio | 18.69 |
3. Growth
3.1 Past
CHEK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 94.63%, which is quite impressive.
EPS 1Y (TTM)94.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.7%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
The Earnings Per Share is expected to grow by 12.32% on average over the next years. This is quite good.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y20.31%
EPS Next 2Y12.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
CHEK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CHEK. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as CHEK's earnings are expected to grow with 12.32% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.32%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for CHEK!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
CHECK CAP LTD
NASDAQ:CHEK (12/24/2024, 8:03:26 PM)
After market: 1.44 -0.11 (-7.1%)1.55
-0.7 (-31.11%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners0.16%
Inst Owner Change62.08%
Ins Owners6.24%
Ins Owner ChangeN/A
Market Cap9.07M
Analysts43.33
Price Target7.14 (360.65%)
Short Float %0.21%
Short Ratio0.47
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | N/A | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.38 | ||
| P/tB | 0.38 | ||
| EV/EBITDA | N/A |
EPS(TTM)-3.01
EYN/A
EPS(NY)-2.64
Fwd EYN/A
FCF(TTM)-2.91
FCFYN/A
OCF(TTM)-2.9
OCFYN/A
SpS0
BVpS4.05
TBVpS4.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -70.22% | ||
| ROE | -74.17% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-47.73%
ROA(5y)-72.09%
ROE(3y)-51.45%
ROE(5y)-92.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 39.15% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 18.69 | ||
| Quick Ratio | 18.69 | ||
| Altman-Z | -5.24 |
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)214.2%
Cap/Depr(5y)207.52%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)94.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.7%
EPS Next Y20.31%
EPS Next 2Y12.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y10.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y11.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y9.39%
OCF growth 3YN/A
OCF growth 5YN/A